nectar lifesciences ltd. neclife · 2020. 10. 31. · tel. +91-17 62-30 8000, fax +91-17 62-30...

3
Nectar Lifesciences Ltd. NecLife Ref No. NLL/CS/2020- 340 Date: 31.10.2020 1. National Stock Exchange of India 2. BSE Limited Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block - G, Dalal Street, Bandra Kurla Complex, MUMBAI - 400001. Bandra (East), MUMBAI - 400051. Sub: Publication of Financial Results Sir's, We are furnishing herewith newspaper copy of Publication of Financial Results of the Company for the quarter and half year ended on September 30, 2020, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 31.10.2020 - circulating in the whole or substantially the whole of India. 2. Desh Sewak (Punjabi) dated 31.10.2020 being published in language of the region where the registered office of the Company is situated. This is for your information and record please. Yours Sincerely, For Nectar Lifesciences Limited (Sanjiv Goyal) Chairman & Managing Director End: a.a. Corporate Office : S.C.O. 38-39, Sector 9-D, Chandigarh-160 009 (India) Tel. : +91-172-304777 Fax : +91-172-3047755 E-mail : [email protected] Website : www.neclife.com CIN : L24232 PB1995 PLC 016664 Regd. Office & Works : Vill. Saidpura, Teh. Dera Bassi, Distt. S.A.S. Nagar (Mohali) 140 507 PUNJAB, Near Chandigarh (INDIA) Tel. : +91-1762-308000, 308001 Fax : +91-01762-281187, 308135

Upload: others

Post on 16-Nov-2020

31 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Nectar Lifesciences Ltd. NecLife · 2020. 10. 31. · Tel. +91-17 62-30 8000, Fax +91-17 62-30 8135, Email : es@neclife.com, Website xtract o Unaudited Results for the Quarter and

Nectar Lifesciences Ltd. NecLife

Ref No. NLL/CS/2020- 340 Date: 31.10.2020

1. National Stock Exchange of India 2. BSE Limited Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block - G, Dalal Street, Bandra Kurla Complex, MUMBAI - 400001. Bandra (East), MUMBAI - 400051.

Sub: Publication of Financial Results

Sir's,

We are furnishing herewith newspaper copy of Publication of Financial Results of

the Company for the quarter and half year ended on September 30, 2020, which

have been published in the following newspapers:

1. Business Standard (English-all editions) dated 31.10.2020 - circulating in the

whole or substantially the whole of India.

2. Desh Sewak (Punjabi) dated 31.10.2020 being published in language of the

region where the registered office of the Company is situated.

This is for your information and record please.

Yours Sincerely,

For Nectar Lifesciences Limited

(Sanjiv Goyal) Chairman & Managing Director

End: a.a.

Corporate Office : S.C.O. 38-39, Sector 9-D, Chandigarh-160 009 (India) Tel. : +91-172-304777 Fax : +91-172-3047755 E-mail : [email protected] Website : www.neclife.com

CIN : L24232 PB1995 PLC 016664 Regd. Office & Works : Vill. Saidpura, Teh. Dera Bassi, Distt. S.A.S. Nagar (Mohali) 140 507 PUNJAB, Near Chandigarh (INDIA)

Tel. : +91-1762-308000, 308001 Fax : +91-01762-281187, 308135

Page 2: Nectar Lifesciences Ltd. NecLife · 2020. 10. 31. · Tel. +91-17 62-30 8000, Fax +91-17 62-30 8135, Email : es@neclife.com, Website xtract o Unaudited Results for the Quarter and

Sr. I Particulars

S

Consolidated

No. 30190201 3819/2919 30121320 I 361512020 1 30/912019 301912020

Quarter ended

Half Year ended

Quarter ended

Half Year ended

1 Total Income from Operations 48,847.49 63,734.98 92,279.06 48,871.34 64,553.29 92,422.14

2 Net Profit 1 (Loss) far the period (before Tax; Exceptional and/or Extraordinary items) (1,096.84) 202.34 (3,663.54) (1,097.51) 258.59 (3,672.26)

3 Net Profit 1 (Lessl for the period before tax (after Exceptional and for Extraordhary items) (1,096.84) 202.34 (3,663.54) (1,097.51) 258.59 (3,672.26)

4 Net Profit 1 (Loss) for the period after tax (after Exceptional and/or Extraordinary items) (730.74) 188.79 (2,413.08) (731.41) 245.04 12,421.801

51 Total Comprehensive Income for the period [Comprising Profit ((Loss) for the period (after tax) and other Comprehensive Income (after tax)) (730.74) 188.79 (2,413.08) (730.92) 227.88 (2.421.361

6 Equity Share Capital 2,242.61 2,242.61 2,242.61 2,242.61 2,242.61 ' 2,242.61

7 Reserves (excluding Revaluation Reserve) as shownin the Audited Balance Sheet of the previous year 111,217.25 111,369.89

8 Earnings Per Share (of Re. 11- each) (for continuing and discontinued operations,-

1. Basic:

2. Diluted:

(0.33)

(0.331

0.08

0.08

(1.08)

(1.08)

(0,33)

10.33)

0.11

0.11

11.081

11.08) Note: I1) The above is an ennui of detailed hornet of Financial Results foi the Guano and half year ended 30.09-2020 lied with the Stock Exchanges under Regulation 33 of the SEBIlListing obligatinro and Disclosure Requirementsillogulettram,2015.The lull format of the financial results for the Quarter and hall year ended en 30.09-2020 are available en the Company's webene i.e. littpliwww.tre,clife.coml investor _relati ons.php Dorton-the websiio of the Stock Exchanges at www.intintlia.com and wirnumseintha.cem.121 Covidi pandemic has been rapidly spreading throughout the world including India. Government in India has taken significant Mang u, Is curb the spread of the vine including hrupesins9mandalury lock downs audios:no nom in activities. Consequent to this. memo far Iliequarterand hail year ended Sept 30, 2020 lie_s been impacted resulting in losses during the quarter and hall yew endadSept 311, 2020.131 Previous year figur as have bear regrouped and reclassified wherever necessary termite them cumparable with current period.

By Order of the Board of Directors of Nectar Lifesciences Limited

(Dr. Dinesh Dua) Executive Director

Dated : 30-10-2020 Place : Chandigarh

Str\1E g.S STA N10 11-RD btit -FED - `3 I - - 2,0 2-0

41-Ned-ifel NECTAR LIFESCIENCES LIMITED Regd. Office: Vill. Saidpura, Tehsif Derabassi. Oistt. S.A.S. Nagar IfMohalil. Punjab -140507.

CIN:1.24232/1131995P1C016564 Tel. +91-17 62-30 8000, Fax +91-17 62-30 8135, Email : [email protected], Website www.neclife.cam

xtract o Unaudited Results for the Quarter and half year ended 30.09.2020 (Rs in Lacs)

le Fortis MAI. AR El:PITAt

FORTIS MALAR HOSPITALS LIMITED aft 16,5110PB1989PLC0459443

Regd. Office. Fortis Hospital, Sector 62, Phase VIII, Mohali-160062

Website: wanv.fortismalaroom Email: [email protected] Tek 0172- 5095001 Fax: 0172- 5096002

NOTICE

pi

"S De

PI

fad

will be tabled in Parliament

by the Union finance

minister. INDIVIAL DHASMANA

Pursuant lo Regulation 47 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure

ia

Requirements) Regulations, 2015, t) Notice is hereby given that a meeting of I s I the Board of Directors of the Company will be held on Friday, November 6, 2020.10 inter alla, consider and approve un-audited financial results for the quarter and period ended on September 30, 2020. The same is also available on the website of the Company - www.forlisrnalaccom and that of BSE Limited -www.bseindia.com.

For Fortis Mahar Hospitals Limited Sd/-

Mayank Jain Company Secretary E

Date: October 30, 2020 Compliance Officer Place: Gurugram It No. A26620

A ea MEGASOFT LIMITED CIN: 1_72200TN1999PLC042730,

Registered Office: #85, Kutchery Road, Mylapore, Chennai, India - 600 004. Corporate Office: 01st Floor, Block-3, My Home Hub, Madhapur, Hyderabad - 500081. Telangana, India_

MEGASOFT Phone: +91-44-24616768 Fax: +91-44-24617810, Email: investorsgmegasoftcom Website - www.megasoft.com

EXTRACT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30 2020

Rs. in iv:Hu

Particulars

Standalone Consolidated Quarter Ended

30/09/2020 (Unaudited)

Hall Year Ended 30/09/2020 (Unaudited)

Quarter Ended 30/09/203.9 (Unaudited)

627.41

Quarter Ended 30/09/2020 (Unaudited)

1537.58

Half Year Ended 30/09/2020 (Unaudited)

2887.59

Quarter Ended 20/09/2013 (Unaudited)

1430.41 Total Income from Operations 404.43 854.66

Net Profit / (Loss) for the period (before Tax. Exceptional and/or Extraordinary items • )

29.00 136.36 9.92 73.15 149.86 11.42

Net Profit / (Loss) for the period before tax (after Exceptional and/or Extraordinary items# )

29,00 136.36 9.92 73.15 149.86 11.42

Net Profit / (Loss) for the period after tax (after Exceptional and/or Extraordinary items• )

29.00 136.36 9.92 73.14 149.85 11.42

Total Comprehensive Income for the period [Comprising Profit I (Loss) for the period (after tax) and Other Comprehensive Income (after tax))

29.00 136.36 9.92 11.42

73.14 149.85

Page 3: Nectar Lifesciences Ltd. NecLife · 2020. 10. 31. · Tel. +91-17 62-30 8000, Fax +91-17 62-30 8135, Email : es@neclife.com, Website xtract o Unaudited Results for the Quarter and

F51 rga * irdibl

Vn.r fqadl aaldig '452/0214rOft 16, i,itadhle,

2018/21052 &MI

018/3651 f>ra . ift2381*6-13fr F5F

Firdre'W-LT

ft*. kiao6.

7,3 afier ,-1;e*

IF craw k. .2011 A -d-6 r Meg

RLSAFr Adld

irar •1-. >rirg"

Fit, P. °fed 8, 4486 3 ra Ef 11T

0(biti err fi-14- fa fn-x-E TR-a-Tv-41. fa Frirz k-3 *cm kreMiT, (ET- RVIIM P>rmkgebinfiza, irfu11 . frWr, trim A-. 89-90, 68, AlriOhr rTdfd 14-470 hffun'a3 'ffMcd nT3- Hieig rde4t,:i kin );(5- rilai:1Zdagn WrAr W1?VI1fiNZ3 4tAcrf fEntErfat isfrg 7,11W371 ft. cose 721-07, 2002 ‘2002 PT 54;'73 NrETN 13(21 •Sfud Whit d'adi Vef;c ad0W fRIT /ifeitgrait fredge 2002 @" yig 3 Kr73 UfTsfr gr* drad au kr-4 fwi• vdwo fi-014.re* fa-1.03 c;;ICH' ire bildr fa-pw AT 4r4 fir farm Fft far iIGH trkra tr 2 fKal 1' 60 fent # lic75 a-aw 'Her &1 d 1 7rt I

catlect daerf astu 41.07 zran rva ona-an Ff cterie.cl/t4ed 4P/f RA" Aare" fErJ krU err we* 4 N 1.6)-Fro3wal 2i 4-6 pi , fev,, NUR' 0* nlaz A2t1175 13(0) 31..14 IN* 37dr37 2t 803 MIFV4fr f0Tr t- 04 gl5 r3 srg ilf171fr dr"6, 6-6 71.73 fwEr edry T fwafie_t f75,7r t. I ocri3e'd t 1PP czat )14-4 wrif yrs ;man fEv Frfua 0114,- 7-evr 4 fa us ant 75rF5 aErT ?sue 7,r

at3T g*, fa-cif-a fEra. Rt2 tftr FI-Phrgiub A-R24nistribit, ufugi Wag-. wire k 89-90. Wan. 68, 4174.141:1 88T9 ir0781" VT WNW' i1 44 nifwat poe, TrFST 5-5+ #111- dalf 44 cire. f4.7rPT4 Zr etnei d4dl I a&EP,iir re+3- fanfrN FERSTkosir PtJer tja 31.242 AMES 13 AU-PIZIEPS 8 3f0'3 ItOzi r f0-MMT riteeV- 6 r~r4 QE 0, RN* real

awes. tr 757

ddtI d .dd OF WV.

05.092005, d 1-1Hed (AA fgr 4077111. Adld i-ITZ,51 I

Wra reFt# ip.r. 131. H6 awra 425 irsF 1:j1- a-ru'a-rg 7775, Cra- Ewa, Hl, craT8i

176123 D-ra ijcua- F11- WS iirearu 3}48 463'

ABNIFf 6d1d, CO*, Fma.aI 33 cldl FFIETFIF gHT5 g-ga. Fa- Era- an-r a, %. 4552 fH31.

il.fee.e )11 11567 ccii451, 7 3 Wh-rff k 1, d.61,t.4T fH31 02 .01 .2019 77r6-077, m-11- fwerg F)1 -3. brat-, th.dle, •

a' d,-f,4 Vff4141 fq4fr4 fug

NM= Ft" 14.072020 2.9.10.2020 • Rs. 1.01,635.63

Rat 3140.2020

Oft •

ITEM Rare

•• • 014EFZEr Kam

1

Frh,of 20/IF Mill) 31VIrilThWnlefl$2126.4

.16.16,61 d 310200Thallf209 1601262e

fa.-Hr&uraw, 'Tr-4r Frqi fawutersor tpww

417 wrzi tr-sx*

wawa- -a--4-n-41qf 8.147,49 734-513 92279336 4E07134 64.56328 92.412:14 it.-, grwmarn lit -tivi ra.p. grT- Mk 44310W5 ..W?).P 8'4705'1 MIMI* 202.34 0.951.541 41.1157311 258.55 13.572264 i rirs ----rf/01Ew? nit par tan eh's' Ery bit/RI +813ERffe:111PW3WWV (►)48.841 2.0234 63453.54) 11,0EL51) 25859 P.,0221:11

4 gl:r ISTS/(alfrer) lei' NEI i-ag3 8'TMc MMI *0/0" »nitirUN Wire t. IMPEJ 1730.74) 188.28 (2,413,00 {731.4i) 245.04 12421.$01

5 Erg- ru-trua new--€-E Hit WE (faw few awn g-, 714-r2r) FR- tire ( -e ax t'' 8w0.) m-k to fine wr ww-el; (tam 1 ammo 1730.741 S88.79 (141314) man 22701 1247,1.38i urgglinga Tat 2.242.01 2.242.81 1 22421 2.24211 2.241B1 2.241M anre t. - ,-1-c-i-Fh--6-. arse` t ft t) ice' fir fuer ART PI 14-,8t tiqrrf fir kg' oaf* farm= al 111,237S5 111,3691a

8 Ire ifIgg VW'S (w. I www) (Ac'- ,a'Kw'

W33 OAS 11.081 0,00.. NM

1033) 80.331

0.11 OA 1

11,181 MOW

zre aGtrd gEk ) 1. gvii. ' [

Tit ; 1. tiagg fawal 41*. *kr' wwila-rrfgat act x9 2020 c RL-31et4iiriPW -.F.r3i9",4# tdt ,411 .F&Pt.j3 f7,TOZA7R) je,Ries 2011 ";.viitir, 33 3110-Mr,diF214-4 kir a:Fe zOrfs.rdrnegilrb-Prwip-aFii-pt30 092(40 t rtttF3WRO--1.14'4W' '11147Sft44-57-2

WEilfFt Eirii14*;arriteP- k tylvtlwww_neaTre.com/Intr. retations.php nt;-; Fria v6wr6se■ncro.0u1 wowenseindiacoth •frerthAtitr UF 12 cii. g.-19 N0,1781- 'Mrs Rira V3Infr .77a- frek' N,W at- .1.1 v,•e-a. 400 • a vlag t iTig get se. azrr kFf f*" d 7,7,01F•erWtirii ,t17, ZTTI Faa<a o a e fitn x-18 577,t 30 Etrie 2020 t 414" €314.71 #r"6" x.4.72 ,,e4 Va 1 44 gviTCr getlre I IV& 30 ggar 2020 Q 731{ 5c fssrffi-.41-4 ‘-j." hi:8Z f1.1117 ,f4* 8 30 Valid 2020

asx tet fw.rt >a*Tgragrg kir u.r4= trE,h-'13. 4rAt"*.eitr ,$0 1.1rs5,4.i1a girer cm; g *imp, ag- nal ffeillf taw wiz rfeixrea

Xaed r.c dti ftSf}reg. Kft

(wr. fret rr voir) rOvey tlolafa

mi el .GE H re H fE)-11-eg • NecLife f.to C1W8 -140 51J?

CIN: L24232P61995P1C016664 +91-1762-308000, :81NR :4-91-1762-308135• gifts :es@rtecliFe_torn www.nectIfe.com

FH-89- 30-09-2E12u -6•- ttwg- ug' Pst- *fa- H' p-r- ma- ∎ -VI

c e a c }WM' WW1' ws-re. s9-911, 'cwt.- 68. Few Aspea

9ES?-1 SCLotrik PUOIA 61

it V:- 3 1 —I el esaacuq, Wit-41a, 31 )3,i'd Tiff 2020

[email protected]

L

11